CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing)device
Likely dose
MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04964128
NCT04964128N/ACompleted
CompareCT.gov

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Medtronic MiniMed, Inc.·interventional·Posted Jul 15, 2021·Updated Sep 13, 2023

In Brief

A clinical study evaluating MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing) for Type 1 Diabetes. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this feasibility study is to evaluate subject safety of using the Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing) within the AHCL system in adult subjects with type 1 diabetes in a clinic setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJul 15, 2021
Enrollment StartJul 22, 2021
Primary CompletionJun 10, 2022
Study CompletionJul 26, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.0 years ago

Interventions

MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing)device

The AHCL system with Meal Gesture Dosing evaluated in this study includes a commercial/CE-Marked insulin pump with investigational software, and the Klue Health mobile app with investigational software (installed on Apple Watch) for meal gesture detection and micro dosing.